MDMA is hosting their most popular event, the FDA Forum, virtually this year. The event is scheduled for 9-10 March. This year’s forum will focus on the latest strategies and insights governing the 510(k) and PMA regulatory pathways.

Laurie Clarke, TSG’s VP of Medical Device Regulatory, will join FDA officials, device industry representatives, and other FDA regulatory professionals in sharing information about FDA’s current and planned regulation of medical devices, as well as the Agency’s COVID-19 efforts.

Interested in speaking with Laurie in advance of the event? Have questions about the evolving regulatory landscape for 510(k), de novo, and PMA submissions? Contact [email protected] and we will be happy to put you in touch with Laurie.